(Q33410375)

English

Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

8 February 2021

Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

8 February 2021

author name string

Brian A Baldo

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043487%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Nghia H Pham

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043487%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 December 2013

2 references

Europe PubMed Central

PubMed publication ID

26 July 2017

8 February 2021

Cancer and Metastasis Reviews

2 references

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043487%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

8 February 2021

32

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043487%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

3-4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043487%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

723-761

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043487%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Adverse drug reactions: definitions, diagnosis, and management

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Pharmacogenetics and adverse drug reactions

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

The mode of action of aspirin and similar compounds

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Non-allergic nature of docetaxel-induced acute hypersensitivity reactions

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Hypersensitivity reactions from antineoplastic agents

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Signal transduction therapy of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Hypersensitivity reactions to cancer chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

The complex clinical picture of presumably allergic side effects to cytostatic drugs: symptoms, pathomechanism, reexposure, and desensitization

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Side Effects of Ifosfamide

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Combination chemotherapy with adriamycin and streptozotocin; II. Clinicopharmacologic correlation of augmented adriamycin toxicity caused by streptozotocin

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Hypersensitivity pneumonitis associated with the use of temozolomide

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Fluorouracil for allergic reactions to capecitabine

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Capecitabine-induced stomatitis: a likely pathogenetic mechanism of oral lichenoid mucositis.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Recurrent palmar-plantar erythrodysaesthesia following high-dose cytarabine treatment for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Hypersensitivity pneumonitis in advanced non-small-cell lung cancer patients receiving gemcitabine and paclitaxel: report of two cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Gemcitabine-induced radiation recall

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Allergic reactions to 6-mercaptopurine during treatment of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Pemetrexed-associated urticarial vasculitis

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Vincristine-induced fever in a child with rhabdomyosarcoma: cellular hypersensitivity to vincristine demonstrated by leukocyte migration test

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Hydroxyurea-induced hypersensitivity pneumonitis: A case report and literature review

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Hypersensitivity Reactions Associated with Platinum Antineoplastic Agents: A Systematic Review

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Phase I pharmacokinetic and pharmacodynamic study of SJG-136, a novel DNA sequence selective minor groove cross-linking agent, in advanced solid tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Topotecan as second-line therapy for ovarian cancer: dosage versus toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Cytotoxic-induced fulminant hyperpyrexia

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Veno-occlusive disease of the liver in right-sided Wilms' tumours

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Bleomycin and the skin

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Phase I study of oral azacitidine in myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

A case of lenalidomide-induced hypersensitivity pneumonitis

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Treatment of ALK-positive non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Pulmonary arterial hypertension in patients treated by dasatinib

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Lichenoid drug eruption with palmoplantar hyperkeratosis due to imatinib mesylate: a case report and a review of the literature.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Chemotherapeutic agents and the skin: An update

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Role of tyrosine kinase inhibitors in cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Mechanisms of adverse effects of anti-VEGF therapy for cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Pleomorphic presentation of cutaneous lesions associated with the proteasome inhibitor bortezomib in patients with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

[Bortezomib-induced neutrophilic dermatosis with CD30+ lymphocytic infiltration].

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Aromatase inhibitor-induced skin adverse reactions: exemestane-related cutaneous vasculitis

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Incidence rate of injection-site granulomas resulting from the administration of luteinizing hormone-releasing hormone analogues for the treatment of prostatic cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Biological correlates of acute hypersensitivity events with DAB(389)IL-2 (denileukin diftitox, ONTAK) in cutaneous T-cell lymphoma: decreased frequency and severity with steroid premedication

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Toxic epidermal necrolysis associated with denileukin diftitox (DAB389IL-2) administration in a patient with follicular large cell lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

The development of pyrrolobenzodiazepines as antitumour agents

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Lenalidomide mode of action: linking bench and clinical findings

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose Levels

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Exemestane: a review of its use in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Goserelin acetate with or without antiandrogen or estrogen in the treatment of patients with advanced prostate cancer: a multicenter, randomized, controlled trial in Japan. Zoladex Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Bicalutamide (Casodex) in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Mechanisms of disease: Oncogene addiction--a rationale for molecular targeting in cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Translation of the Philadelphia chromosome into therapy for CML.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Rational development of histone deacetylase inhibitors as anticancer agents: a review

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

The optimal use of bexarotene in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Pralatrexate: basic understanding and clinical development

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Denileukin diftitox: a biotherapeutic paradigm shift in the treatment of lymphoid-derived disorders

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Aflibercept (VEGF Trap) in inoperable stage III or stage iv melanoma of cutaneous or uveal origin

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

The docking protein p130Cas regulates cell sensitivity to proteasome inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Proteasome inhibitors: an expanding army attacking a unique target

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Compliance and effective management of the hand-foot syndrome in colon cancer patients receiving capecitabine as adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Idiosyncratic drug reactions: current understanding

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

The investigation of bronchospasm during induction of anaesthesia.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Skin testing and hypersensitivity reactions to oxaliplatin

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000-2007.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Thrombocytopenia in adult cancer patients receiving cytotoxic chemotherapy: results from a retrospective hospital-based cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Severe thrombocytopenia induced by a single infusion of trastuzumab

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Autoimmune thrombocytopenia: a complication of fludarabine therapy in lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Immune-Mediated Thrombocytopenia Following Dactinomycin Therapy in a Child With Alveolar Rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Cyclophosphamide-induced immune thrombocytopenia in a patient with ovarian carcinoma successfully treated with intravenous gamma globulin

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Immune-mediated thrombocytopenia secondary to suramin

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Oxaliplatin-induced Evan's syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Neutropenia management

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Congenital and acquired neutropenia

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Delayed onset of autoimmune hemolytic anemia complicating cladribine therapy for Waldenström macroglobulinemia

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Carboplatin-induced immune hemolytic anemia

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Cutaneous vasculitis in breast cancer treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Tamoxifen and purpuric vasculitis

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Cutaneous vasculitis due to cyclophosphamide therapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Desensitization regimens for drug allergy: state of the art in the 21st century

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Idiosyncratic reaction after oxaliplatin infusion

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

The cytosine arabinoside (Ara-C) syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Mucocutaneous reactions to chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Idiosyncratic drug hepatotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Histological patterns in drug-induced liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Allergic hepatitis induced by drugs

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Mechanisms of immune-mediated liver injury

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Management of hypersensivity pneumonitis

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Bronchiolitis obliterans organizing pneumonia, 25 years: a variety of causes, but what are the treatment options?

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Drug induced interstitial lung disease.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Chemotherapy-induced lung disease

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Microangiopathic hemolytic anemia, thrombocytopenia, and renal failure in patients treated for adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

The tumor lysis syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Recommendations for the implementation of platelet autoantibody testing in clinical trials of immune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Indications for imatinib mesylate therapy and clinical management

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

The taxanes: toxicity and quality of life considerations in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Successful desensitization protocol for hypersensitivity reaction caused by sunitinib in a patient with a gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Tumor angiogenesis: past, present and the near future

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Modes of resistance to anti-angiogenic therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Cellular abnormalities of blood vessels as targets in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Targeting HIF-1 for cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Hypoxia--a key regulatory factor in tumour growth

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

The role of hypoxia-inducible factors in tumorigenesis.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Semaphorin signals tweaking the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Met, metastasis, motility and more

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

HIF-1 as a target for drug development

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Hypoxia inducible factor as a cancer drug target

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Schedule-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Role of the VEGF/VEGFR axis in cancer biology and therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Marked activity of irinotecan and rapamycin combination toward colon cancer cells in vivo and in vitro is mediated through cooperative modulation of the mammalian target of rapamycin/hypoxia-inducible factor-1alpha axis

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

A cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

VEGF-Trap: a VEGF blocker with potent antitumor effects

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Double antiangiogenic protein, DAAP, targeting VEGF-A and angiopoietins in tumor angiogenesis, metastasis, and vascular leakage

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Targeting the angiopoietin/Tie2 pathway: cutting tumor vessels with a double-edged sword?

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Matrix metalloproteinases: roles in cancer and metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Immune hemolytic anemia associated with drug therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9447-3

21 January 2018

Three cases of chemotherapy-induced acral erythema

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid desensitization with temozolomide in patients with delayed maculopapular rash.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irinotecan-induced immune thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute anaphylactic reactions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe autoimmune hemolytic anemia in eight patients treated with fludarabine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophilic hidradenitis induced by chemotherapy involves eccrine and apocrine glands

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug-induced pruritic micropapular eruption: anastrozole, a commonly used aromatase inhibitor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Severe cutaneous toxicity after Pemetrexed as second line treatment for a refractory non small cell lung cancer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topotecan as a continuous infusion over 14 days in recurrent ovarian cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclic lymphocytic vasculitis associated with chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anaphylactoid reactions to narcotic analgesics

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High dose-intensity of irinotecan administered every 3 weeks in advanced cancer patients: a feasibility study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review: Drug-induced neutropenia--pathophysiology, clinical features, and management.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tamoxifen-related vasculitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypersensitivity reactions to deoxycoformycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atopic hypersensitivity to L-asparaginase. Resistance to immunosuppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anaphylaxis to L-asparaginase during treatment for acute lymphoblastic leukemia in children--evidence of a complement-mediated mechanism

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug-induced vasculitis: a clinical and pathological review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin-induced hemolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug-induced immune thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[A case of cutaneous vasculitis caused by erlotinib treatment and a review of literature].

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allergic reactions to mitoxantrone

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel-induced hypersensitivity pneumonitis: radiographic and CT findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anaphylaxis during anaesthesia: current aspects of diagnosis and prevention.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mucocutaneous paraneoplastic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer 2025: Radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypersensitivity reactions to iv melphalan during treatment of multiple myeloma: Cancer and Leukemia Group B experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Desensitization to imatinib in patients with leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International drug monitoring: the role of national centres. Report of a WHO meeting

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate pneumonitis. Bronchoalveolar lavage findings suggest an immunologic disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosine (cladribine).

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypoxia and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new rapid desensitization protocol for chemotherapy agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune-mediated agranulocytosis related to drugs and their metabolites: mode of sensitization and heterogeneity of antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leg ulcers and hydroxyurea: forty-one cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allergic reactions to cyclophosphamide: delayed clinical expression associated with positive immediate skin tests to drug metabolites in five patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypersensitivity reactions to carboplatin and cisplatin in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammation of actinic keratoses from systemic chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutaneous reactions after treatment with 2-chlorodeoxyadenosine

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platin salts-induced hemolytic anemia: cisplatin- and the first case of carboplatin-induced hemolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug-induced immune hemolytic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type III and type IV hypersensitivity reactions due to mitomycin C

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute bronchospasm after a vinca alkaloid in patients previously treated with mitomycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dermatologic toxicities of targeted anticancer therapies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunochemical perspectives of allergy: in the steps of Karl Landsteiner.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohemolytic anemia following oxaliplatin administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophilic eccrine hidradenitis. A distinctive type of neutrophilic dermatosis associated with myelogenous leukemia and chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hand-foot-syndrome associated with medical tumor therapy - classification and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypersensitivity reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allergic reactions to cytotoxic drugs--an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutaneous toxicity following the administration of dactinomycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric carcinoma and thrombotic thrombocytopenic purpura: association with plasma immune complex concentrations

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drugs associated with bullous pemphigoid. A case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug-induced lung disease: high-resolution CT findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generalized hypersensitivity reaction to intravesical thiotepa and doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chlorambucil-associated pneumonitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug-induced immune neutropenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allergy-induced hepatic toxicity associated with dacarbazine

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fatal hepatitis C associated fibrosing cholestatic hepatitis as a complication of cyclophosphamide and corticosteroid treatment of active glomerulonephritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune-mediated thrombocytopenia following dactinomycin therapy in a child with alveolar rhabdomyosarcoma: the unresolved issues

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fludarabine and autoimmune hemolytic anemia in chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutaneous eruptions of lymphocyte recovery

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxaliplatin may induce cytokine-release syndrome in colorectal cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Acute diffuse interstitial pneumopathy following docetaxel (Taxotère). Apropos of 2 cases]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An exceptional case of hypersensitivity to actinomycin D. Case report and review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical features of hypersensitivity reactions to carboplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological mechanisms of drug-induced liver injury.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Syndrome of acute dyspnea related to combined mitomycin plus vinca alkaloid chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/24043487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10555-013-9447-3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043487%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043487%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043487%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33410375&oldid=2195334429"